UBS/CALL/GALENICA/70.002/0.05/20.12.24 | Real-time Bid/Ask 05:07:29 2024-06-20 am EDT | ||
| 0.32 CHF / 0.33 CHF | +4.84% |
|
| Current month | -11.43% | ||
| 1 month | +24.00% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
GALENICA AG
| Date | Price | Change |
|---|---|---|
| 24-06-19 | 0.31 | +6.90% |
| 24-06-17 | 0.29 | -6.45% |
| 24-06-13 | 0.31 | -6.06% |
| 24-06-12 | 0.33 | -2.94% |
Delayed Quote Swiss Exchange
Last update June 19, 2024 at 11:20 am EDT
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | GALENICA AG |
| Issuer | UBS |
| FGALZU | |
| ISIN | CH1276040891 |
| Date issued | 2023-06-19 |
| Strike | 70 CHF |
| Maturity | 2024-12-20 (184 Days) |
| Parity | 20 : 1 |
| Emission price | 0.45 CHF |
| Emission volume | N/A |
| Settlement | physical |
| Currency | CHF |
Technical Indicators
| Highest since issue | 0.47 CHF |
|---|---|
| Lowest since issue | 0.19 CHF |
| Spread | 0.01 CHF |
| Spread % | 3.23% |
Company Profile
Galenica AG, previously Galenica Sante Ltd, is a Switzerland-based healthcare services and products provider. The Company's business i divided into three business sectors: Retail, Products & Brands, and Services. The Company manages a locally established pharmacies network in Switzerland. It develops and distributes its own product portfolio, as well as cooperates with a range of business partners, such as Pierre Fabre, Ales Groupe and Vitor Consumer Health for marketing and distribution of such brands as Perskindol, Triofan, A-Derma, Lierac, Phyto, Anti-Brumm and Algifor. Galenica Sante's Services business sector is responsible for management of such logistics sector companies as Galexis, Unione Farmaceutica Distribuzione, Alloga and Medifilm.
Sector
-
Consensus: Galenica AG
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
73.6
CHF
Average target price
77
CHF
Spread / Average Target
+4.62%
- Stock Market
- Warrants
- FGALZU Warrant
